OSI Pharmaceuticals To Release Year-End Financial Results On December 12, 2002; Conference Call...

Business Editors & Health/Medical Writers

MELVILLE, N.Y.--(BUSINESS WIRE)--Dec. 9, 2002

OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) today announced its financial results will be released on December 12, 2002 at 7:00AM Eastern Time. At 8:00AM OSI will webcast a conference call

To access the live call or the seven-day archive via the Internet, log on to www.osip.com. Please connect to the Company's website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to view the webcast. Alternatively, please call 1-800-360-9865 (U.S.) or 1-973-694-6836 (international) to listen to the call. Telephone replay is available approximately two hours after the call through December 19, 2002. To access the replay, please call 1-800-428-6051 (U.S.) or 1-973-709-2089 (international). The conference ID number is 271498.

OSI Pharmaceuticals, Inc. is a leading biotechnology company focused on the discovery, development and commercialization of high-quality, next-generation oncology products that both extend and improve the quality-of-life for cancer patients worldwide. The Company has a balanced pipeline of oncology drug candidates that includes both next-generation cytotoxic agents and novel mechanism-based, gene-targeted therapeutics. OSI's most advanced drug candidate, Tarceva(TM) (erlotinib HCl), a small-molecule inhibitor of the EGFR gene, is currently in Phase III clinical trials for lung and pancreatic cancers.